According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...
A new study conducted by researchers from Charles University (Prague, Czech Republic) has uncovered a significant LINK between obstructive sleep apnea syndrome and increased mortality among ...
Key Takeaways Untreated sleep apnea contributes to car crashesPatients who got no treatment were 21% more likely to be in a ...
A new study published in the journal of Sleep and Breathing found that people with obstructive sleep apnea (OSA) were 43% ...
An 8-week weight loss and lifestyle intervention improved vitamin D levels up to 6 months after treatment among men with OSA and high BMI.
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.